Veratridine: A Benchmark Voltage-Gated Sodium Channel Opener for Neuroscience and Oncology Research

Executive Summary: Veratridine (CAS: 71-62-5) is a well-characterized steroidal alkaloid neurotoxin extracted from Veratrum species, used primarily as a voltage-gated sodium channel opener in research (APExBIO). It binds selectively to site 2 on sodium channels, resulting in persistent depolarization of excitable membranes (Saito et al., 2025). This mechanism underpins its central role in sodium channel dynamics, excitotoxicity, and seizure mechanism studies. Veratridine also functions as a UBXN2A protein enhancer, with demonstrated applications in cancer cell pathway research. Its high solubility in DMSO, defined storage requirements, and dose-dependent effects on cell death have made it a reference compound for sodium channel blocker screening assays.

Biological Rationale

Voltage-gated sodium channels regulate action potential initiation and propagation in excitable cells, including neurons and cardiomyocytes (internal article). Disruptions in sodium channel function are implicated in neurological disorders, cardiac arrhythmias, and various cancer pathologies. Veratridine, by preventing inactivation of these channels, serves as a pharmacological probe to dissect the molecular basis of these diseases. Its role as a sodium channel opener provides a controlled method to induce depolarization, enabling systematic study of channel gating, cell excitotoxicity, and downstream signaling events (Saito et al., 2025).

Mechanism of Action of Veratridine

Veratridine binds to neurotoxin site 2 on voltage-gated sodium channels, stabilizing the open state by inhibiting channel inactivation. This action causes sustained influx of Na⁺ ions, leading to persistent depolarization of neuronal and muscle membranes. The molecular formula of veratridine is C₃₆H₅₁NO₁₁, with a molecular weight of 673.79 g/mol. Its solubility exceeds 33.69 mg/mL in DMSO, facilitating preparation of concentrated stock solutions for laboratory use (APExBIO). At the cellular level, this persistent depolarization can trigger downstream pathways, including activation of caspase-mediated cell death and modulation of UBXN2A and mortalin-2 dependent mechanisms, particularly relevant in cancer biology (internal article).

Evidence & Benchmarks

• Veratridine induces persistent depolarization by binding site 2 of voltage-gated sodium channels, preventing inactivation in both neuronal and cardiac models (Saito et al., 2025).
• In cell culture, veratridine enhances UBXN2A protein levels and induces dose-dependent cancer cell death via mortalin-2 dependent pathways (APExBIO).
• Animal studies: intraperitoneal injection of veratridine at 0.125 mg/kg for 28 days led to increased UBXN2A expression and significant colon cancer cell death (Saito et al., 2025).
• Veratridine is used as a gold-standard positive control in screening assays for sodium channel blockers, ensuring assay sensitivity and reproducibility (internal article).
• Veratridine-induced sodium influx is quantifiable via electrophysiology and calcium imaging, providing robust readouts for both basic and applied research (internal article).

Applications, Limits & Misconceptions

Veratridine's applications span sodium channel dynamics research, excitotoxicity modeling, seizure mechanism elucidation, and cancer chemosensitivity studies. It is especially valuable in:

• Dissecting sodium channel gating and persistent depolarization events.
• Screening candidate sodium channel blockers in high-throughput assays.
• Inducing cell death in cancer models via UBXN2A and mortalin-2 pathways (internal article).
• Validating sodium channel function in induced pluripotent stem cell-derived cardiomyocytes (Saito et al., 2025).

Compared to other sodium channel openers, veratridine is noted for its specificity, reproducibility, and well-documented dose-response profiles (internal article), extending guidance beyond previous scenario-driven discussions by detailing molecular targets and validated protocols.

Common Pitfalls or Misconceptions

• Not a diagnostic or therapeutic agent: Veratridine is for research use only and is not approved for clinical diagnosis or therapy (APExBIO).
• Long-term solution storage: Stock solutions should be used promptly; prolonged storage leads to degradation and loss of potency.
• Non-specific cytotoxicity at high doses: Excessive concentrations can cause widespread depolarization and cell death unrelated to sodium channel specificity.
• Limited selectivity for sodium channel subtypes: Veratridine does not discriminate among sodium channel isoforms, which may confound subtype-specific studies.
• Not suitable for in vivo human studies: Potency and toxicity restrict use to animal models or cell systems only.

Workflow Integration & Parameters

Veratridine (SKU B7219) is supplied as a white solid, soluble in DMSO at concentrations >33.69 mg/mL (>10 mM). For experimental use, prepare fresh DMSO stock solutions and dilute in physiological buffers immediately prior to cell or tissue application. Store powder at -20°C, protected from light and moisture. In vitro, effective concentrations range from 1 to 100 μM, with exposure times tailored to cell type and readout. In vivo, dosing regimens such as 0.125 mg/kg intraperitoneally over 28 days have been employed in murine cancer models (Saito et al., 2025).

For sodium channel blocker screening, veratridine is used as a positive control to induce reproducible sodium influx, benchmarking assay performance (internal article). This article extends prior internal guidance by emphasizing precise solubility, storage, and protocol parameters critical for reproducibility.

Conclusion & Outlook

Veratridine remains a cornerstone reagent for sodium channel research, cancer chemosensitivity studies, and pharmacological screening. Its robust mechanism, validated in both cellular and animal models, underpins its value as a standard for benchmarking and assay development. Ongoing advances in sodium channel subtype analysis and UBXN2A pathway mapping may further expand its utility. For researchers requiring a validated, high-purity sodium channel opener, Veratridine from APExBIO delivers superior reproducibility and experimental confidence, as documented across peer-reviewed and scenario-driven studies.